Projected Income Statement: CONMED Corporation

Forecast Balance Sheet: CONMED Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 664 1,026 950 881 794 741 638 519
Change - 54.52% -7.41% -7.26% -9.88% -6.69% -13.9% -18.65%
Announcement Date 26/01/22 02/02/23 31/01/24 05/02/25 28/01/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: CONMED Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 14.87 21.78 19.03 13.08 19.81 19 27 28
Change - 46.54% -12.64% -31.25% 51.38% -4.07% 42.11% 3.7%
Free Cash Flow (FCF) 1 96.9 11.58 106.3 153.9 150.9 214 164.6 167
Change - -88.05% 818.1% 44.74% -1.95% 41.86% -23.13% 1.49%
Announcement Date 26/01/22 02/02/23 31/01/24 05/02/25 28/01/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: CONMED Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 19.51% 18.05% 18.92% 20.32% 20.07% 20.5% 20.58% 20.78%
EBIT Margin (%) 14.18% 12.55% 14.01% 15.51% 15.71% 15.67% 15.81% 16.6%
EBT Margin (%) - - - 12.47% 5.17% 13.31% 13.79% -
Net margin (%) 6.19% -7.71% 5.18% 10.13% 3.42% 8.54% 9.42% 9.43%
FCF margin (%) 9.59% 1.11% 8.54% 11.77% 10.98% 15.67% 11.48% 11.05%
FCF / Net Income (%) 154.94% -14.37% 164.94% 116.21% 320.65% 183.42% 121.9% 117.13%

Profitability

        
ROA 5.65% 4.04% 4.71% 5.75% 6.18% 5.86% 5.87% 6.02%
ROE 13.3% 10.71% 13.71% 14.74% 14.34% 12.81% 11.75% 11.46%

Financial Health

        
Leverage (Debt/EBITDA) 3.37x 5.44x 4.03x 3.32x 2.88x 2.65x 2.16x 1.65x
Debt / Free cash flow 6.85x 88.59x 8.93x 5.73x 5.26x 3.46x 3.88x 3.11x

Capital Intensity

        
CAPEX / Current Assets (%) 1.47% 2.08% 1.53% 1% 1.44% 1.39% 1.88% 1.85%
CAPEX / EBITDA (%) 7.54% 11.54% 8.08% 4.93% 7.18% 6.79% 9.15% 8.92%
CAPEX / FCF (%) 15.34% 188.13% 17.9% 8.5% 13.13% 8.88% 16.41% 16.77%

Items per share

        
Cash flow per share 1 - 1.111 3.973 5.36 5.48 4.257 4.425 -
Change - - 257.72% 34.91% 2.23% -22.32% 3.97% -
Dividend per Share 1 0.8 0.8 0.8 0.8 0.8 - - -
Change - 0% 0% 0% 0% - - -
Book Value Per Share 1 26.93 24.82 27.12 31.15 36.87 38.06 43.45 49.62
Change - -7.85% 9.26% 14.89% 18.36% 3.23% 14.16% 14.19%
EPS 1 1.94 -2.68 2.04 4.25 1.51 3.88 4.49 4.79
Change - -238.14% 176.12% 108.33% -64.47% 156.95% 15.72% 6.68%
Nbr of stocks (in thousands) 29,247 30,482 30,752 30,891 30,968 29,951 29,951 29,951
Announcement Date 26/01/22 02/02/23 31/01/24 05/02/25 28/01/26 - - -
1USD
Estimates
2026 *2027 *
P/E 11.9x 10.3x
PBR 1.22x 1.07x
EV / Sales 1.56x 1.41x
Yield - -

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
46.30USD
Average target price
45.50USD
Spread / Average Target
-1.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CNMD Stock
  4. Financials CONMED Corporation